Abstract

The present study was carried out to investigate antibacterial activity of ceftobiprole and vancomycin in-vitro and in-vivo after inducing osteomyelitis in rabbit by administration of Methicillin Resistant Staphylococcus Aureus (MRSA). Part I, evaluation is done in-vitro by using hot plate method for appearance zone of inhibition and Minimum Inhibitory Concentration (MIC) against (MRSA). Antibacterial susceptibility test showed that the ceftobiprole was more effective than vancomycin. Part II, inducing osteomyelitis (40 mg/kg B.W) compared with treated with vancomycin at a dose of (30 mg/kg B.W) subcutaneously for 28 days. Ceftobiprole succeeded to treat osteomyelitis by absence methicillin resistant staphylococcus aureus in the infected rabbits and prevented infection compared with vancomycin and radiographic pictures explained normal bone anatomy and all features of osteomyelitis disappeared These results indicate that ceftobiprole provided effective parenteral treatment of osteomyelit is in this rabbit model.

Keywords:

Ceftobiprole , osteomyelitis, rabbit, staphylococcus aureus, vancomycin,

References

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.